RECENT PAST NEWS IN MDR-TB

Children at Risk of Multidrug-Resistant TB Get Prevention Option

resisttb

Jan 51 min read

J&J denied extension of patent on TB drug, to benefit patients

resisttb

Dec 4, 20241 min read

Armand Van Deun Scholarship Initiative

resisttb

Dec 4, 20241 min read

Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB

resisttb

Nov 12, 20241 min read

Can John Green Make You Care About Tuberculosis?

resisttb

Nov 12, 20241 min read

Only $1.50 to Detect TB Infection With the Next-Generation SIILTIBCY Test

resisttb

Nov 12, 20241 min read

Tuberculosis resurges as top infectious disease killer

resisttb

Oct 10, 20241 min read

Fighting drug-resistant TB was costly. Here's how that's changed

resisttb

Oct 10, 20241 min read

WHO releases updated guidelines on tuberculosis preventive treatment

resisttb

Sep 22, 20241 min read

TB diagnosis and drug resistance testing can be reduced to just 23 hours

resisttb

Sep 2, 20241 min read

Major advance in the fight against MDR-TB: four new short and effective treatments from independent clinical trials approved by the WHO

resisttb

Aug 15, 20241 min read

The Competition Commission of South Africa has initiated another important complaint involving TB drugs

resisttb

Aug 15, 20241 min read

Relief in South Africa after J&J reversal allows key tuberculosis drug production at lower prices

resisttb

Aug 11, 20241 min read

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB

resisttb

May 10, 20241 min read

Symposium on Emerging Resistance to Novel Tuberculosis Drugs

resisttb

Apr 25, 20241 min read

Treatment Action Group - Report from the 1/4/6×24 Campaign

resisttb

Apr 25, 20241 min read

Treat Action Group 2023 Pipeline Report

resisttb

Mar 13, 20241 min read

The Rejection of the Bedaquiline Patent Opposition in Indonesia Raises the Risk of Difficulty in Accessing Optimal TB Therapy

resisttb

Feb 6, 20241 min read

To Prepare For The Next Pandemic, We Must Spend Now On TB And Other Major Diseases

resisttb

Feb 6, 20241 min read

RECENT PAST NEWS IN MDR-TB

Children at Risk of Multidrug-Resistant TB Get Prevention Option

J&J denied extension of patent on TB drug, to benefit patients

Armand Van Deun Scholarship Initiative

Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB

Can John Green Make You Care About Tuberculosis?

Only $1.50 to Detect TB Infection With the Next-Generation SIILTIBCY Test

Tuberculosis resurges as top infectious disease killer

Fighting drug-resistant TB was costly. Here's how that's changed

WHO releases updated guidelines on tuberculosis preventive treatment

TB diagnosis and drug resistance testing can be reduced to just 23 hours

Major advance in the fight against MDR-TB: four new short and effective treatments from independent clinical trials approved by the WHO

The Competition Commission of South Africa has initiated another important complaint involving TB drugs

Relief in South Africa after J&J reversal allows key tuberculosis drug production at lower prices

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB

Symposium on Emerging Resistance to Novel Tuberculosis Drugs

Treatment Action Group - Report from the 1/4/6×24 Campaign

Treat Action Group 2023 Pipeline Report

The Rejection of the Bedaquiline Patent Opposition in Indonesia Raises the Risk of Difficulty in Accessing Optimal TB Therapy

To Prepare For The Next Pandemic, We Must Spend Now On TB And Other Major Diseases

WHO European Region: Data collection guide - indicators for meaningful involvement of civil society in TB response